Irwin Naturals announced that it has completed the acquisition of its first ketamine clinic, Midwest Ketafusion, an infusion clinic that offers intravenous ketamine for the treatment of depression, PTSD, OCD, anxiety, bipolar disorder, migraines, and multiple chronic pain conditions such as complex regional pain syndrome (CRPS), reflex sympathetic dystrophy (RSD), and fibromyalgia.
In consideration of the acquisition, 7,500 proportionate voting shares of the company were issued. Each proportionate voting share is convertible into 100 subordinate voting shares.
The clinic will be rebranded as Emergence by Irwin Naturals. Read more.
